Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Clinical and Translational Medicine|May 4, 2023
Post-transplant cyclophosphamide as sole GHVD prophylaxis after matched reduced-intensity conditioning allotransplantAmandine Le Bourgeois, Maxime Jullien, Alice Garnier, et al.Cancers|April 13, 2024
Late Relapse after Allogeneic Stem Cell Transplantation in Patients Treated for Acute Myeloid Leukemia: Relapse Incidence, Characteristics, Role of Conditioning Regimen, and OutcomeChloé Antier, Maxime Jullien, Benoît Tessoulin, et al.Hematological Oncology|April 25, 2022
Effectiveness of a third dose of BNT162b2 anti-SARS-CoV-2 mRNA vaccine over a 6-month follow-up period in allogenic hematopoietic stem cells recipientsPatrice Chevallier, Maxime Jullien, Pierre Peterlin, et al.Ejhaem|November 29, 2023
Assessment of monocytic-myeloid-derived suppressive cells (M-MDSC) before and after allogeneic hematopoietic stem cell transplantation in acute leukemia patientsPierre Peterlin, Marie C Béné, Maxime Jullien, et al.Human Vaccines & Immunotherapeutics|July 8, 2024
Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplantValentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, et al.Journal of Cellular and Molecular Medicine|October 13, 2022
Peripheral levels of monocytic myeloid-derived suppressive cells before and after first induction predict relapse and survivals in AML patientsPierre Peterlin, Camille Debord, Marion Eveillard, et al.Acta Haematologica|June 20, 2022
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case ReportPierre Peterlin, Alice Garnier, Amandine Le Bourgeois, et al.Bone Marrow Transplantation|April 16, 2025
Posaconazole versus fluconazole as primary antifungal prophylaxis for patients at high risk of invasive fungal infections receiving allogeneic hematopoietic stem cell transplantationValentin Letailleur, Maxime Jullien, Alice Garnier, et al.Bone Marrow Transplantation|June 28, 2022
Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignanciesYannick Le Bris, Domitille Costes, Raphaël Bourgade, et al.Pageof 7